Skip to main content
Equibles
XGN logo

XGN · Exagen Inc. · Metrics

Track XGN — free

Use XGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.27 -0.21 (-2.81%) At close · Oct 23
Rebalance outlook locked
Market Cap
$176.12M
Shares
24.23M
Volume · Oct 23 222.8K Avg daily vol (3M) 358.01K

XGN metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.27
Market cap
$176.12M

Price action

20 metrics
Price change (1W)
-5.8%
Price change (30D)
-16.6%
Price change (3M)
+55.3%
Price change (6M)
+169.3%
Price change (YTD)
+19.6%
Price change (1Y)
-39.0%
Trailing year
Price change (5Y)
-40.9%
52-week high
$11.96
52-week low
$2.65
Change from 52-week high
-39.2%
Change from 52-week low
+174.3%
Annualized volatility
83.6%
Annualized volatility (3M)
94.3%
Beta
2.5
RSI (14D)
40.5
Price vs SMA 50
-6.9%
Price vs SMA 200
+46.4%
Avg volume (3M)
358,007
Relative volume
0.6
Average dollar volume
$2.62M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
24.23M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.5×
reciprocal yield 40.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.5×
reciprocal yield 40.4%
P / book
14.4
reciprocal yield 6.9%
FCF yield
-4.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-10.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 73.8%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 78.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
58.6%
Operating margin
-18.6%
Trailing 12 months
Net margin
-26.6%
Gross profit (TTM)
$41.70M
Operating profit (TTM)
−$13.21M
Net income (TTM)
−$18.92M
Trailing 12 months
Diluted EPS (TTM)
$-0.82
FCF margin
-10.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.01
Gross profit per diluted share (TTM)
$1.76
Operating profit per diluted share (TTM)
$-0.56
EBITDA per diluted share (TTM)
$-0.46
Net income per diluted share (TTM)
$-0.81
Operating cash flow per diluted share (TTM)
$-0.27
Free cash flow per diluted share (TTM)
$-0.32
Capital expenditures per diluted share (TTM)
$0.05
R&D per diluted share (TTM)
$0.27
Stock compensation per diluted share (TTM)
$0.12
Book value per share
$0.76

Growth

11 metrics
Revenue growth YoY
+15.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$71.12M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+14.6%
Year over year · more shares
Revenue CAGR (3Y)
+13.5%
Revenue CAGR (5Y)
+9.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-154.9%
Return on assets
-36.4%
Debt / equity
1.9
Current ratio
3.2
EBITDA (TTM)
−$10.81M
Free cash flow (TTM)
−$7.59M
Quick ratio
3.2
Interest coverage
-2.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.75M
Latest balance sheet
Cash & equivalents
$24.59M
Total assets
$51.94M
Total debt
$22.84M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.50M
Capital expenditures (TTM)
$1.09M
R&D (TTM)
$6.47M
SG&A (TTM)
$48.45M
Stock compensation (TTM)
$2.93M
R&D / revenue
9.1%
Stock compensation / revenue
4.1%

Ownership (13F)

9 metrics
13F filers
57
13F filer change QoQ
-4
Institutional ownership
32.8%
Conviction holders (share of 13F filers)
3.5%
Crowding (high-turnover and private-fund holders)
20.6%
Private-fund adviser ownership
18.2%
Active holders' share change QoQ
-19.4%
Holder tenure
7.0
Price vs estimated holder cost
-26.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.4%

Short interest

3 metrics
Short interest
2.9%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$418,572
Insider-sentiment score
26 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1274737 CUSIP 30068X103 13F (30d) 2 filings 2 filers Visit website Investor relations